Literature DB >> 28209712

Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages.

Srabasti Sengupta1, Saba Naz2, Ishani Das1, Abdul Ahad3, Avinash Padhi1, Sumanta Kumar Naik1, Geetanjali Ganguli1, Kali Prasad Pattanaik1, Sunil Kumar Raghav3, Vinay Kumar Nandicoori2, Avinash Sonawane4.   

Abstract

Mycobacterium tuberculosis is known to modulate the host immune responses to facilitate its persistence inside the host cells. One of the key mechanisms includes repression of class-II transactivator (CIITA) and MHC-II expression in infected macrophages. However, the precise mechanism of CIITA and MHC-II down-regulation is not well studied. M. tuberculosis 6-kDa early secretory antigenic target (ESAT-6) is a known potent virulence and antigenic determinant. The M. tuberculosis genome encodes 23 such ESAT-6 family proteins. We herein report that M. tuberculosis and M. bovis bacillus Calmette-Guérin infection down-regulated the expression of CIITA/MHC-II by inducing hypermethylation in histone H3 lysine 9 (H3K9me2/3). Further, we showed that M. tuberculosis ESAT-6 family protein EsxL, encoded by Rv1198, is responsible for the down-regulation of CIITA/MHC-II by inducing H3K9me2/3. We further report that M. tuberculosis esxL induced the expression of nitric-oxide synthase, NO production, and p38 MAPK pathway, which in turn was responsible for the increased H3K9me2/3 in CIITA via up-regulation of euchromatic histone-lysine N-methyltransferase 2 (G9a). In contrast, inhibition of nitric-oxide synthase, p38 MAPK, and G9a abrogated H3K9me2/3, resulting in increased CIITA expression. A chromatin immunoprecipitation assay confirmed that hypermethylation at the promoter IV region of CIITA is mainly responsible for CIITA down-regulation and subsequent antigen presentation. We found that co-culture of macrophages infected with esxL-expressing M. smegmatis and mouse splenocytes led to down-regulation of IL-2, a key cytokine involved in T-cell proliferation. In summary, we demonstrate that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK activation.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  EsxL; Mycobacterium smegmatis; Mycobacterium tuberculosis; histone methylation; macrophage; major histocompatibility complex (MHC); nitric oxide; nitric oxide synthase; p38 MAPK

Mesh:

Substances:

Year:  2017        PMID: 28209712      PMCID: PMC5409457          DOI: 10.1074/jbc.M117.775205

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Histone modifications induced by a family of bacterial toxins.

Authors:  Mélanie Anne Hamon; Eric Batsché; Béatrice Régnault; To Nam Tham; Stéphanie Seveau; Christian Muchardt; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

Review 2.  Modifiable risk factors in periodontal disease: epigenetic regulation of gene expression in the inflammatory response.

Authors:  Silvana P Barros; Steven Offenbacher
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  Mycobacterium tuberculosis 6 kDa early secreted antigenic target stimulates activation of J774 macrophages.

Authors:  Gyanesh Singh; Balwan Singh; Vladimir Trajkovic; Pawan Sharma
Journal:  Immunol Lett       Date:  2004-12-08       Impact factor: 3.685

Review 5.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.

Authors:  Clifford V Harding; W Henry Boom
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

6.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Expression of Mycobacterium tuberculosis NLPC/p60 family protein Rv0024 induce biofilm formation and resistance against cell wall acting anti-tuberculosis drugs in Mycobacterium smegmatis.

Authors:  Avinash Padhi; Sumanta Kumar Naik; Srabasti Sengupta; Geetanjali Ganguli; Avinash Sonawane
Journal:  Microbes Infect       Date:  2015-12-17       Impact factor: 2.700

Review 8.  Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis.

Authors:  Volker Briken; Jessica L Miller
Journal:  Future Microbiol       Date:  2008-08       Impact factor: 3.165

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection.

Authors:  Katherine J Siddle; Matthieu Deschamps; Ludovic Tailleux; Yohann Nédélec; Julien Pothlichet; Geanncarlo Lugo-Villarino; Valentina Libri; Brigitte Gicquel; Olivier Neyrolles; Guillaume Laval; Etienne Patin; Luis B Barreiro; Lluís Quintana-Murci
Journal:  Genome Res       Date:  2014-01-30       Impact factor: 9.043

View more
  6 in total

1.  Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications.

Authors:  H Al Tbeishat
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.996

2.  Mycobacterium tuberculosis Modulates miR-106b-5p to Control Cathepsin S Expression Resulting in Higher Pathogen Survival and Poor T-Cell Activation.

Authors:  David Pires; Elliott M Bernard; João Palma Pombo; Nuno Carmo; Catarina Fialho; Maximiliano Gabriel Gutierrez; Paulo Bettencourt; Elsa Anes
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

Review 3.  Development of New Preventive and Therapeutic Vaccines for Tuberculosis.

Authors:  Bo-Eun Kwon; Jae-Hee Ahn; Seunghwan Min; Hyeongseop Kim; Jungheun Seo; Sang-Gu Yeo; Hyun-Jeong Ko
Journal:  Immune Netw       Date:  2018-04-03       Impact factor: 6.303

4.  A temperature sensitive Mycobacterium paragordonae induces enhanced protective immune responses against mycobacterial infections in the mouse model.

Authors:  Byoung-Jun Kim; Bo-Ram Kim; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

5.  An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.

Authors:  Arshad Khan; Pearl Bakhru; Subramanian Dhandayuthapani; Chinnaswamy Jagannath; Sankaralingam Saikolappan; Kishore Das; Emily Soudani; Christopher R Singh; Jaymie L Estrella; Dekai Zhang; Chandrashekhar Pasare; Yue Ma; Jianjun Sun; Jin Wang; Robert L Hunter; N Tony Eissa
Journal:  NPJ Vaccines       Date:  2019-08-05       Impact factor: 7.344

6.  An attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathology.

Authors:  Helena Strand Clemmensen; Niels Peter Hell Knudsen; Erik Michael Rasmussen; Jessica Winkler; Ida Rosenkrands; Ahmad Ahmad; Troels Lillebaek; David R Sherman; Peter Lawætz Andersen; Claus Aagaard
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.